The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 01, 2019

Filed:

Aug. 24, 2016
Applicant:

Ventana Medical Systems, Inc., Tuscon, AZ (US);

Inventors:

Christopher Bieniarz, Tucson, AZ (US);

Julia Ashworth-Sharpe, Tuscon, AZ (US);

Brian D. Kelly, Tuscon, AZ (US);

Nathan Polaske, Oracle, AZ (US);

Assignee:
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C07F 9/12 (2006.01); C07F 9/14 (2006.01); C07H 15/203 (2006.01); C07H 15/26 (2006.01); C07H 17/02 (2006.01); C07D 209/14 (2006.01); C07D 403/06 (2006.01); G01N 33/58 (2006.01); C07F 9/58 (2006.01); C07F 9/6503 (2006.01); C07F 9/6558 (2006.01); C07F 9/6561 (2006.01); C07F 9/6518 (2006.01); C07F 9/6533 (2006.01);
U.S. Cl.
CPC ...
G01N 33/581 (2013.01); C07D 209/14 (2013.01); C07D 403/06 (2013.01); C07F 9/12 (2013.01); C07F 9/581 (2013.01); C07F 9/65033 (2013.01); C07F 9/6561 (2013.01); C07F 9/65185 (2013.01); C07F 9/65335 (2013.01); C07F 9/65583 (2013.01); C07H 15/203 (2013.01); C07H 15/26 (2013.01); C07H 17/02 (2013.01);
Abstract

Disclosed herein are novel quinone methide analog precursors and embodiments of a method and a kit of using the same for detecting one or more targets in a biological sample. The method of detection comprises contacting the sample with a detection probe, then contacting the sample with a labeling conjugate that comprises an enzyme. The enzyme interacts with a quinone methide analog precursor comprising a detectable label, forming a reactive quinone methide analog, which binds to the biological sample proximally to or directly on the target. The detectable label is then detected. In some embodiments, multiple targets can be detected by multiple quinone methide analog precursors interacting with different enzymes without the need for an enzyme deactivation step.


Find Patent Forward Citations

Loading…